Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
RESEARCH TOOLSreports
Holding RXRX?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 26.08M | $ 14.42M | $ 13.79M | $ 10.62M | $ 10.10M |
| Gross Profit | $ 14.00M | $ 5.22M | $ 2.63M | $ 744.00K | $ -775.00K |
| EBIT | $ -95.11M | $ -97.69M | $ -92.13M | - | $ -92.99M |
| EBITDA | $ -87.92M | $ -88.72M | $ -84.75M | - | $ -85.41M |
| Net Income Common Stockholders | $ -95.84M | $ -97.54M | $ -91.37M | $ -93.00M | $ -93.02M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 427.65M | $ 474.34M | $ 296.33M | $ 391.56M | $ 387.32M |
| Total Assets | $ 726.50M | $ 775.86M | $ 557.85M | $ 653.70M | $ 630.83M |
| Total Debt | $ 90.63M | $ 89.88M | $ 50.97M | $ 50.67M | $ 51.48M |
| Net Debt | $ -337.02M | $ -384.46M | $ -245.35M | $ -340.89M | $ -335.85M |
| Total Liabilities | $ 201.94M | $ 191.41M | $ 156.70M | $ 190.26M | $ 192.86M |
| Stockholders Equity | $ 524.56M | $ 540.98M | $ 401.15M | $ 463.44M | $ 437.97M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -63.79M | $ -86.40M | $ -108.95M | - | $ -73.75M |
| Operating Cash Flow | $ -59.23M | $ -82.22M | $ -102.30M | $ -74.08M | $ -72.92M |
| Investing Cash Flow | $ -4.56M | $ -4.18M | $ -6.65M | $ -2.49M | $ -347.00K |
| Financing Cash Flow | $ 16.46M | $ 263.12M | $ 13.90M | $ 80.66M | $ 53.77M |